Abbott Laboratories (ABT)

Add a New Bears Reason Company: Abbott Laboratories (ABT) Current price: Headline: (100 character max) Analysis: Cancel 0% agree 4 votes edit Pipeline questions Top Contributor: Will Shikani | Created when NYSE:ABT was $52.17 | Edit | History With the expiration the patent for its multi-application drug Depakote, Abbott will lose major revenue to generic copies. (100 character max) Cancel 16% agree 6 votes edit Medicare could negatively affect Abbott's pricing in the long run Top Contributor: Kryssia Uraguchi | Created when NYSE:ABT was $53.80 | Edit | History Although new Medicare reform has covered Humira, which will boost sales, it could negatively affect Abbott's pricing in the long run. As Medicare continues to be reformed, more prescription drugs will be covered. If Abbott is forced to lower their prices, it will hurt the revenues in the pharmaceutical division. (100 character max) Cancel 16% agree 6 votes edit Abbott's R&D expenditures are much less than their competition Top Contributor: Kryssia Uraguchi | Created when NYSE:ABT was $53.80 | Edit | History Abbott's R&D expenditures are much less than their competition. R&D is very important in the pharmaceutical industry and could put Abbott at a disadvantage, especially with expiring drug patents. (100 character max) Cancel

Worried about pump and dump? We review changes for stock spam » read more

Want to make Wikinvest better? We need your help, contribute today » learn how

Do you write software? We are recruiting the best engineers » view jobs

Like Wikinvest? Spread the word — Tell your friends! » spread the word

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

About | Blog | Advertise | Jobs | Feedback | Help | Get involved